- Editorials The growing burden of non-alcoholic fatty liver disease on mortality
- Ju-Yeon Cho, Won Sohn
- Clin Mol Hepatol. 2023;29(2):374-376.
- Letters to the Editor Forms of cholangitis to be considered after SARS-CoV-2 infection
- Ju-Yeon Cho, Young-Sun Lee, Soon Sun Kim, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim
- Clin Mol Hepatol. 2022;28(4):929-930.
- Special Topic Update on liver disease management during the pandemic of coronavirus disease 2019 (COVID-19): 2021 KASL guideline
- Ju-Yeon Cho, Young-Sun Lee, Soon Sun Kim, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim
- Clin Mol Hepatol. 2021;27(4):515-523.
- Management of liver diseases during the pandemic of coronavirus disease-19
- Ju-Yeon Cho, Soon Sun Kim, Young-Sun Lee, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim
- Clin Mol Hepatol. 2020;26(3):243-250.
- Original Articles Risk score model for the development of hepatocellular carcinoma in treatment-naïve patients receiving oral antiviral treatment for chronic hepatitis B
- Won Sohn, Ju-Yeon Cho, Ji Hoon Kim, Jung Il Lee, Hyung Joon Kim, Min-Ah Woo, Sin-Ho Jung, Yong-Han Paik
- Clin Mol Hepatol. 2017;23(2):170-178.
- Clinical significance and predictive factors of early massive recurrence after radiofrequency ablation in patients with a single small hepatocellular carcinoma
- Ju-Yeon Cho, Moon Seok Choi, Gil Sun Lee, Won Sohn, Jemma Ahn, Dong-Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
- Clin Mol Hepatol. 2016;22(4):477-486.